Giulia Carla M.
- Country
- Italy
- Department
- S.C. Malattie Infettive e Tropicali
Research Overview
- Lenacapavir with Teropavimab and Zinlirvimab (twice‑yearly) versus Cabotegravir/Rilpivirine in virologically suppressed adults with HIV‑1
- Cohort study of human mpox virus disease
- Evaluation of Efficacy, Safety, and Tolerability of Switching from Bictegravir/Emtricitabine/Tenofovir Alafenamide to Dolutegravir/Lamivudine in Virologically Suppressed HIV Patients Aged 50+
Data & Insights
Has run more than one trial at 101 of 230 partner sites.
Specializations
Infectious Disease Management
The investigator specializes in treating various infectious conditions, with particular expertise in respiratory infections and pneumonia management. Their work extends to studying treatment outcomes in hospital settings.
- Acute respiratory conditions
- Hospital-based treatment protocols
- Patient recovery monitoring
Their research encompasses emergency response protocols and treatment effectiveness in acute care settings.
HIV Treatment Innovation
The investigator focuses on advanced HIV treatment strategies, particularly studying various antiretroviral combinations and treatment optimization. They specialize in managing treatment-experienced patients and those with late-stage presentations.
- Antiretroviral therapy optimization
- Treatment switching strategies
- Long-term viral suppression
Their work includes evaluating innovative treatment approaches for both newly diagnosed and experienced HIV patients.
Emerging Viral Diseases
The investigator contributes to research on emerging viral infections, including studies on mpox virus disease. Their work involves evaluating treatment outcomes and therapeutic responses to antiviral medications.
- Viral disease management
- Antiviral treatment assessment
- Clinical outcome analysis
Their research encompasses monitoring treatment efficacy and patient response to various therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.